Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Cancer Control : Journal of the Moffitt Cancer Center|June 5, 2020
Electrocardiographic Changes Associated With Ibrutinib ExposureMichael G Fradley, Allan Welter-Frost, Matthew Gliksman, et al.Journal of Leukocyte Biology|June 16, 2004
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteinsAnja Moldenhauer, Richard C Frank, Javier Pinilla-Ibarz, et al.Clinical Lymphoma, Myeloma & Leukemia|March 20, 2016
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH StudyJorge E Cortes, Jeffrey H Lipton, Carole B Miller, et al.Cancer|September 26, 2019
Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trialHeather S L Jim, Kelly A Hyland, Ashley M Nelson, et al.International Journal of Hematology|October 5, 2014
Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemiaKendra Sweet, Najla H Al Ali, Samir M Dalia, et al.Clinical Lymphoma, Myeloma & Leukemia|November 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center ExperienceMohamed A Kharfan-Dabaja, Ambuj Kumar, Facundo E Stingo, et al.Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution ExperienceJulio C Chavez, Samir Dalia, Jose Sandoval-Sus, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 7, 2021
Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapyLaura B Oswald, Kelly A Hyland, Sarah L Eisel, et al.Cancer Research|June 26, 2012
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunityFengdong Cheng, Hongwei Wang, Pedro Horna, et al.BMC Cancer|November 10, 2023
Melanoma and CLL co-occurrence and survival: role of KC historyYayi Zhao, Rossybelle P Amorrortu, Sandra C Stewart, et al.Pageof 16